Aims: Considering the sparse information about the clinical utility of the novel immunohistochemical marker ProEx C in histologic sections a decision was taken to study the pattern of ProEx C expression in normal/benign cervical epithelium (N/B), low-grade squamous intraepithelial lesion (LGSIL), and high-grade squamous intraepithelial lesion (HGSIL), as well as the association of ProEx C expression with human papillomavirus (HPV) genotypes.
Methods: One hundred cervical samples including 21 N/B cervices, 16 LGSIL, 61 HGSIL and 2 cervical invasive carcinomas obtained from conization and hysterectomy surgical specimens were arranged in three tissue microarrays and stained for ProEx C. Ninety-three samples were HPV genotyped. Genotypes were performed by DNA amplification and hybridization with genotype specific probes on a low density DNA array.
Results: ProEx C positive expression above the lower one third of the epithelium was observed in 14.3% of N/B, in 62.5% of LGSIL and in 90.2% of HGSIL. Seventy percent of HPV positivity was found in cases with expression above the lower one third of the epithelium. Of 31 cases that were positive for HPV16, 16.1% showed ProEx C expression restricted to 1-2 basal layers and 83.9% showed ProEx C expression above the lower one third of the epithelium.
Conclusions: ProEx C is significantly associated with HPV16 infection and is a useful adjunct in the identification of LGSIL and HGSIL in histologic sections when expressed in more than the lower one third of the epithelium.
Statistics from Altmetric.com
web only appendix 62/2/159